1. Home
  2. NRC vs AVXL Comparison

NRC vs AVXL Comparison

Compare NRC & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Research Corporation (Delaware)

NRC

National Research Corporation (Delaware)

HOLD

Current Price

$17.70

Market Cap

428.2M

Sector

Health Care

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$4.45

Market Cap

430.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRC
AVXL
Founded
1981
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.2M
430.9M
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
NRC
AVXL
Price
$17.70
$4.45
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$22.00
AVG Volume (30 Days)
102.3K
895.1K
Earning Date
04-27-2026
05-12-2026
Dividend Yield
3.69%
N/A
EPS Growth
4707.69
N/A
EPS
50.00
N/A
Revenue
$119,686,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.35
N/A
Revenue Growth
1.81
N/A
52 Week Low
$9.76
$2.86
52 Week High
$22.79
$13.99

Technical Indicators

Market Signals
Indicator
NRC
AVXL
Relative Strength Index (RSI) 63.68 49.93
Support Level $14.78 $3.60
Resistance Level $18.27 $4.88
Average True Range (ATR) 1.01 0.28
MACD 0.42 -0.05
Stochastic Oscillator 88.99 36.09

Price Performance

Historical Comparison
NRC
AVXL

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: